T1	Participants 792 946	112 patients with potentially curable pancreatic head cancer were enrolled and intraoperatively randomized to a standard or extended lymphadenectomy group
T2	Participants 1011 1060	A hundred and one eligible patients were analyzed
T3	Participants 1062 1142	Demographic and histopathological characteristics of the two groups were similar
